Dermatomyositis: Meaning of myositis-associated autoantibodies for diagnosis, clinical course and prognosis;Dermatomyositis: Die bedeutung myositis-assoziierter autoantikörper für diagnose, klinik und prognose

H+G Zeitschrift fur Hautkrankheiten

Volumn 77, Issue 1, 2002, Pages 6-12

  Weihrauch, J ^a   Hunzelmann, N ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Course of the disease; Dermatomyositis; Disease specific autoantibodies; Therapy

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; MALE; PATHOGENESIS; PROGNOSIS;

EID: 18244362620     PISSN: 03010481     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2002.01075.x     Document Type: Article

References (40)

1. Elevated cancer incidence in patients with dermatomyositis: A population based study
2. Polymyositis and dermatomyositis
3. Rrp6p, the yeast homologue of the human PMScl 100 kDa autoantigen is essential for efficient 5.8S rRNA 3′ end formation
4. Prednisone and azathioprine for polymyositis
5. Dermatomyositis
6. Cutaneous photosensitivity in dermatomyositis
7. Cancer risk following polymyositis and dermatomyositis: A nationwide cohort-study in Denmark
8. Controlled studies with high-dose intravenous immunglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis
9. Molecular immunology and genetics of inflammatory muscle diseases
10. A controlled trial of highdose intravenous immune globulin infusions as treatment for dermatomyositis
11. Juvenile dermatomyositis treated with cyclosporine
12. MRI in inflammatory myopthies
13. Autoantikörper bei dermatound polymyositiden
14. Entzündliche muskelerkrankungen aus internistischer sicht
15. Cardiac manifestations in dermato-polymyositis
16. Human anti-p68 autoantibodies recognize a common epitope of u1 RNA containing small nuclear ribonucleoprotein and influenza B virus
17. Anti-KS: Identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease
18. Drug therapy of the idiopathic inflammatory myopathies: Predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficiacy
19. Dermatomyositis
20. Polymyositis-dermatomyositis and malignant lesions: Does an association exist?
21. Dermatomyositis - Diagnostische wertigkeit der kapillarmikroskopie
22. A new approach to the classification of idiopathic inflammatory myopathy: Myositis - Specific autoantibodies define useful homogeneous patient groups
23. New developments in the role of cytokines and chemokines in inflammatory myopathies
24. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis
25. Pulmonary involvement in polymyositis and in dermatomyositis
26. Myositis autoantibody inhibits histidyl-tRNA synthetase: A model for autoimmunity
27. Strong association of dermatomyositis-specific Mi-2 autoantibodies with tryptophan at position 9 of the HLA-DR beta chain
28. Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti Jo-1 autoantibodies
29. An update on juvenile dermatomyositis
30. Morphologische und funktionelle veränderungen an nagelfalzkapillaren bei dermatomyositis
31. Nasopharyngeal carcinoma with dermatomyositis: Analysis of 12 cases
32. NIH conference. Myositis: Immunologic contributions to understanding cause, pathogenesis and therapy
33. Risk of cancer with dermatomyositis or polymyositis
34. Extramuscular manifestations in idiopathic inflammatory myopathies
35. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies
36. Autoantibodies in polymyositis
37. Update on myositis specific and myositis-associated autoantibodies
38. Ovarian cancer in patients with dermatomyositis
39. Scleroderma-polymyositis overlap syndrome associated with antiKU antibody and rimmed vacuole formation
40. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance